Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
ConditionHuman Papillomavirus
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age21+
SponsorM.D. Anderson Cancer Center
About this trial
To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.
Eligibility criteria
Qualifiers
People with a cervix 21 years of age or older.
Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy.
Willing and able to provide informed consent.
Able to perform protocol-required activities. Able to speak and read English or Spanish.
Disqualifiers
Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy.
Participant or provider decision not to collect a sample for this study.
Participants that are pregnant.
Trial design
Treatments tested in this trial
- Novel point-of-care diagnostic test for detecting HPV ("Rice HPV test")
Treatment groups
600 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov